COVID-19 has changed the way society operates in countless ways. During our inaugural podcast, our team of addiction specialists and HIV providers, Drs. Alex Walley, Jessica Taylor and Sim Kimmel from Boston Medical Center, discuss how COVID-19 has not only increased vulnerability among our patient population, it has challenged them to innovate and safely provide services.
Drs. Walley, Taylor, and Kimmell will discuss case study that will illustrate the role for medications for opioid use disorder (MOUD), such as buprenorphine and methadone in HIV prevention among people who inject drugs. They will also outline regulatory changes during the COVID-19 public health emergency that facilitated MOUD access to populations at high risk of HIV acquisition and other complications of substance use disorder. And they will describe barriers and facilitators of OUD and HIV care during the pandemic.
-
How can organizations of all types adapt to providing HIV and OUD care during the COVID-19 pandemic?
- What HIV and OUD systems changes should be continued after the pandemic no longer requires social distancing?
Additional Resources
Low Barrier Tele-Buprenorphine in the Time of COVID-19:A Case Report
Miriam Harris, MD, MSc, Samantha Johnson, BA, Sarah Mackin, MPH, Richard Saitz, MD, MPH, Alexander Y. Walley, MD, MSc, and Jessica L. Taylor, MD
Addict Med Volume 14, Issue 4, July/August 2020
Listen/Subscribe
Spotify (Apple and Google Podcasts coming soon!)
